₹5,000 Monthly SIP in Nippon India Pharma Fund-Growth Plan for 10 Years
If you had started a ₹5,000/month SIP on 28 Sept 2016 and never stopped — through every crash and rally — here is exactly what happened, using Nippon India Pharma Fund-Growth Plan's actual NAV for all 121 installments.
You invested
₹6,05,000
121 installments
Value today
₹15,32,472
28 Sept 2026
Absolute gain
+₹9,27,472
+153.3%
XIRR (annualised)
17.57%
money-weighted
The journey, month by month
Worst fall on the way
-19.5%
Deepest drop from peak. This is what you had to sit through.
Corrections survived
4
Falls of 10%+ during the period. Every one recovered.
Same SIP in a fixed deposit
₹8,43,236
Modelled at historical FD rates. The fund beat FD by ₹6,89,236.
Year-by-year progress
| Year | Invested | Value | Overall gain |
|---|---|---|---|
| Year 1 (28 Sept 2017) | ₹65,000 | ₹61,598 | -5.2% |
| Year 2 (28 Sept 2018) | ₹1,25,000 | ₹1,43,856 | +15.1% |
| Year 3 (30 Sept 2019) | ₹1,85,000 | ₹1,84,114 | -0.5% |
| Year 4 (28 Sept 2020) | ₹2,45,000 | ₹3,78,427 | +54.5% |
| Year 5 (28 Sept 2021) | ₹3,05,000 | ₹5,82,160 | +90.9% |
| Year 6 (28 Sept 2022) | ₹3,65,000 | ₹5,83,046 | +59.7% |
| Year 7 (29 Sept 2023) | ₹4,25,000 | ₹8,17,165 | +92.3% |
| Year 8 (30 Sept 2024) | ₹4,85,000 | ₹12,87,827 | +165.5% |
| Year 9 (29 Sept 2025) | ₹5,45,000 | ₹12,85,398 | +135.9% |
| Year 10 (28 Sept 2026) | ₹6,05,000 | ₹15,32,472 | +153.3% |
Best year of the journey: Year 4 (+55% market move) · Toughest year: Year 3 (-9.7%)
Wealth Time Machine
Watch this exact journey as a 60-second cinematic replay
Every crash headline, every recovery — with your money in it.
Try a different amount
Try a different duration
Past performance does not guarantee future returns. This page shows the historical result of the stated SIP using Nippon India Pharma Fund-Growth Plan's published NAV (source: AMFI) between 28 Sept 2016 and 28 Sept 2026; it is educational research, not investment advice. FD comparison is modelled at historical average FD rates. Mutual fund investments are subject to market risks.